McVernon J, Slack M P E, Ramsay M E
Immunisation Department, Health Protection Agency Centre for Infections, Colindale, London, UK.
Epidemiol Infect. 2006 Jun;134(3):570-2. doi: 10.1017/S0950268805005546. Epub 2005 Nov 17.
Paediatric cases of epiglottitis declined markedly in England following the introduction of safe effective immunization against Haemophilus influenzae type b (Hib). With the recently described resurgence in Hib infections, a corresponding rise in the number of presentations of clinical epiglottitis in children was observed, although numbers were still well below those reported prior to vaccine availability. This was seen both in microbiology reports and hospital admissions data for England. In keeping with the more diverse aetiology of epiglottitis in adults, Hib vaccination had minimal impact on hospital presentations with upper airway infections in those aged 15 years and over, which showed an overall increasing trend over 10 years. The need for a high index of suspicion to allow early diagnosis of this life-threatening clinical presentation is reinforced.
在引入针对b型流感嗜血杆菌(Hib)的安全有效疫苗后,英格兰的小儿会厌炎病例显著减少。随着最近描述的Hib感染复发情况,观察到儿童临床会厌炎就诊人数相应增加,尽管人数仍远低于疫苗可用之前报告的数量。这在英格兰的微生物学报告和医院入院数据中均有体现。与成人会厌炎病因更多样化一致,Hib疫苗接种对15岁及以上人群因上呼吸道感染导致的医院就诊影响极小,这些人群在10年期间总体呈上升趋势。这进一步强调了对这种危及生命的临床表现进行早期诊断时需要高度警惕。